Goldman Sachs Exits Apple Card Partnership Stock Enters Potential Buy Zone MidMarket PE Fundraising Shows Recovery but Smaller Managers May Still Face Challenges abcoffee Secures 61 Crore in PreSeries B Funding Led by Kliff Ventures Fintech Firm Mercury Reaches 52 Billion Valuation Amid Sector Resilience Cambodian Opposition Leaders Partial Pardon Signals Potential Shift in Business Reputation AnheuserBusch InBev Shares Dip as Revenue Falls Short of Market Expectations NVE Corporation NVEC Q1 2026 Earnings EPS of 102 Reported Stock Advances 421 FBRT Q1 2026 Earnings Significant EPS Miss Amidst Challenging Market Conditions SWBI Q1 2026 Earnings Earnings per Share Beat Estimates Revenue Details Not Provided THRY Q1 2026 Earnings Significant EPS Beat Surprises Market Gartner IT Q1 2026 Earnings EPS Surges Past Estimates Despite Stock Pullback Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Lifts Sentiment Gladstone Land LAND Shows Modest Uptick as It Approaches Key Resistance Level INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level Hongli Group HLP Falls 33 as Shares Approach Key 042 Support Zone AFGC Inches Up as Subordinated Debt Finds Steady Footing Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range The One Rule That Can Help Investors Avoid Sophisticated Financial Scams FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business OraSure Technologies OSUR Surges 9 Key Levels to Watch After Strong Move Galata Acquisition Corp II LATA Holds Steady at 1005 Amid PreCombination Stasis Tucows Inc TCX Holds Steady Near Support as Trading Volume Remains Subdued Brookfield Infrastructure Notes BIPH Hold Steady Near 1639 as Yield Attracts Income Seekers Andretti Acquisition Corp II POLE Holds Steady Near Trust Value Amid Minimal Volatility John Wiley Sons WLYB Slides 17 as Publishing Sector Faces Headwinds Roman DBDR Acquisition Corp II Unit DRDBU Holds Steady at 1052 as Support Levels Are Tested Edgewise Therapeutics EWTX Holds Steady Near Support Amid Biotech Trading Lull